Wednesday, June 23, 2021
Home Top Stories Setback for Covaxin, US FDA rejects emergency use nod, suggests ‘full approval’...

Setback for Covaxin, US FDA rejects emergency use nod, suggests ‘full approval’ route

In a setback to Bharat Biotech’s Covaxin, the US FDA has “recommended” Ocugen Inc, the US partner, to go for Biologics Licence Application (BLA) route with additional data.

Covaxin in US

The development may delay Covaxin’s launch in the US. (Reuters)

In a setback to Bharat Biotech’s COVID-19 vaccine Covaxin, the US Food and Drug Administration has “recommended” Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixinghopes of Emergency Use Authorisation.

Ocugen in a statement on Thursday announced that as recommended by the FDA, it will pursue submission of a biologics licence application (BLA) for Covaxin. BLA, is a “full approval” mechanism by the FDA for drugs and vaccines.

“The company will no longer pursue an Emergency Use Authorization (EUA) for Covaxin. The FDA provided feedback to Ocugen regarding the Master File. The company had previously submitted and recommended that Ocugen pursue a BLA submission instead of an EUA application for its vaccine candidate and requested additional information and data,” Ocugen said.

The development may delay the Covaxin launch in the US, Ocugen said. Ocugen is in discussions with the FDA to understand the additional information required to support a BLA submission.

The company anticipates that data from an additional clinical trial will be required to support the submission.

“Although we were close to finalising our EUA application for submission, we received a recommendation from the FDA to pursue a BLA path. While this will extend our timelines, we are committed to bringing Covaxin to the US,”

Dr. Shankar Musunuri, Chairman of the Board, Chief Executive Officer and co-founder of Ocugen said.

“This differentiated vaccine is a critical tool to include in our national arsenal given its potential to address the SARS-CoV-2 variants, including the delta variant, and given the unknowns about what will be needed to protect US population in the long term,” he added.

Ocugen recently announced that it secured exclusive rights to commercialise Covaxin in Canada and has initiated discussions with Health Canada for regulatory approval.

The company will pursue expedited authorisation for the vaccine under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 in Canada.

Click here for IndiaToday.in’s complete coverage of the coronavirus pandemic.

Source link

RELATED ARTICLES

No need to worry, will retrieve AIADMK, says Sasikala after party passes resolution warning cadres

The AIADMK on Monday expelled 16 members of the party and passed a resolution calling for action against any member who speaks with...

No prior sanction required to probe corruption charges against Anil Deshmukh: CBI to court

The CBI has urged the Bombay High Court to dismiss a petition filed by former Maharashtra home minister Anil Deshmukh seeking quashing of...

Anupam Kher shares Kirron Kher’s video message thanking fans for sweet birthdays wishes

Kirron Kher’s fans and followers showered love upon the actress on her 69th birthday. Kirron, who is currently battling cancer, thanked everyone in...

Most Popular

New York mayoral election: Yang out as ex-police officer leads primary

The winning Democratic candidate is likely to become the city's next mayor in a November vote. Source link

Govt to encourage start-ups for elderly care

Within two weeks of the launch of SAGE (Seniorcare Aging Growth Engine) initiative to encourage start-ups engaged in elderly care products and services,...

Nishad Party demands deputy CM post from BJP if alliance wins 2022 UP Assembly polls

The Nishad Party, an ally of the Bharatiya Janata Party (BJP) in Uttar Pradesh, has demanded that its chief Sanjay Nishad be made...

Ramdev Challenges Cases Filed Over Allopathy Remarks In Supreme Court

<!-- -->Ramdev had withdrawn his comments following a letter from Union health minister Dr Harsh Vardhan.New Delhi: Yoga teacher Ramdev -- who infuriated...